Yesterday morning addiction-focused telemedicine company Workit Health announced a new Series A funding round led by Blue Cross Blue Shield Venture Partners for an undisclosed amount. Other funders include Endeavor Catalyst, Montage Ventures, Lux Capital, Wakestream Ventures, Invest Detroit and RRE Ventures.
This marks the second funding round for the Californian startup. Originally founded in 2015 by Robin McIntosh and Lisa McLaughlin, the company’s first financial boost came in 2016 when it scored $1.1 million in seed funding.
What they do
Workit Health provides online addiction treatment to patients recovering from opioid use. The platform helps support patients who are on the medication Suboxone (buprenophine) or Vivitrol (naltrexone) and provides therapy.
The platform lets patients meet with their clinicians and addiction coaches through the virtual program. Users can also join recovery groups and complete addiction courses on their phone. Members are able to get personalized curriculum of tailored courses and set their own goals.
What it’s for
As a result of the funding, Workit Health will be teaming up with Blue Cross Blue Shield Ventures. The companies said the next step is to expand Workit Health’s treatment plan across the US. Currently it is focused on Michigan and California.
“Blue Cross Blue Shield Companies lead the way in delivering access to innovative, cost-effective care, keeping client needs front and center,” Robin McIntosh, Workit’s cofounder, said in a statement. “A partnership naturally evolved from this shared value set, and our Workit Health team is looking forward to working together and delivering the results we currently offer at scale — translating to meaningful outcomes for members, and a return on investment for health plans.”
Market snap shot
In the past five years the rate of opioid-related deaths has soared. In fact, CDC reported 47,600 opioid-related deaths in 2017.
Now the conversation around how to treat opioid addiction has come to the tech world. Even the federal government has started contests for innovators to address this issue. Last month the FDA announced the winners of its opioid addiction innovation challenge. The agency selected eight winners from 250 applicants.
A November Rock Health report suggested that digital tools could be one of the ways the country could address this epidemic. It went on to outline how technology could help with opioid-related data collection and expanding the scope of treatment.
On the record
“The stakes couldn’t be higher as the overdose epidemic continues across the U.S,” Lisa McLaughlin, Workit’s cofounder said in a statement. “For too long, we’ve relied on all-or-nothing, abstinence-based treatment. Workit’s combination of convenient, mobile-first, patient-led design solutions paired with a disruptively low cost enables more individuals to receive treatment than ever before. Our work with payors shows better outcomes, translating to material cost savings, meaning everyone wins.”